Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley R Riddell

Showing results (151-160 of 177) with videos related to

Pageof 18
Sort By:
Nature Biotechnology|November 1, 2022
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapyAlfredo Quijano-Rubio, Aladdin M Bhuiyan, Huilin Yang, et al.
Journal for Immunotherapy of Cancer|October 16, 2014
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cellsSeth M Pollack, Robin L Jones, Erik A Farrar, et al.
Journal for Immunotherapy of Cancer|November 14, 2020
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapySylvain Simon, Valentin Voillet, Virginie Vignard, et al.
The Lancet. Oncology|July 6, 2023
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trialAndrew J Cowan, Margot J Pont, Blythe D Sather, et al.
The Journal of Clinical Investigation|April 26, 2016
CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patientsCameron J Turtle, Laïla-Aïcha Hanafi, Carolina Berger, et al.
Blood Advances|January 17, 2025
Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALLJordan Gauthier, Emily C Liang, Jennifer J Huang, et al.
Cancer Cell|December 28, 2020
Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint BlockadeShivani Srivastava, Scott N Furlan, Carla A Jaeger-Ruckstuhl, et al.
Cancer Cell|April 12, 2022
Neoantigen-specific CD4<sup>+</sup> T cells in human melanoma have diverse differentiation states and correlate with CD8<sup>+</sup> T cell, macrophage, and B cell functionJoshua R Veatch, Sylvia M Lee, Carolyn Shasha, et al.
Nature Communications|April 10, 2026
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combinationLinda Warmuth, Sarah Dötsch, Manuel Trebo, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapyKaran Kohli, Lu Yao, Theodore Scott Nowicki, et al.
Pageof 18

Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Nature Biotechnology|November 1, 2022
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapyAlfredo Quijano-Rubio, Aladdin M Bhuiyan, Huilin Yang, et al.
Journal for Immunotherapy of Cancer|October 16, 2014
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cellsSeth M Pollack, Robin L Jones, Erik A Farrar, et al.
Journal for Immunotherapy of Cancer|November 14, 2020
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapySylvain Simon, Valentin Voillet, Virginie Vignard, et al.
The Lancet. Oncology|July 6, 2023
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trialAndrew J Cowan, Margot J Pont, Blythe D Sather, et al.
The Journal of Clinical Investigation|April 26, 2016
CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patientsCameron J Turtle, Laïla-Aïcha Hanafi, Carolina Berger, et al.
Blood Advances|January 17, 2025
Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALLJordan Gauthier, Emily C Liang, Jennifer J Huang, et al.
Cancer Cell|December 28, 2020
Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint BlockadeShivani Srivastava, Scott N Furlan, Carla A Jaeger-Ruckstuhl, et al.
Cancer Cell|April 12, 2022
Neoantigen-specific CD4<sup>+</sup> T cells in human melanoma have diverse differentiation states and correlate with CD8<sup>+</sup> T cell, macrophage, and B cell functionJoshua R Veatch, Sylvia M Lee, Carolyn Shasha, et al.
Nature Communications|April 10, 2026
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combinationLinda Warmuth, Sarah Dötsch, Manuel Trebo, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapyKaran Kohli, Lu Yao, Theodore Scott Nowicki, et al.
Pageof 18